Latham Steers Cancer Therapy Biz In $130M IPO Filing
Clinical-stage cancer therapy company Zentalis Pharmaceuticals LLC said Monday it plans to raise about $130 million in a Latham & Watkins LLP-steered initial public offering, if its shares price at midpoint....To view the full article, register now.
Already a subscriber? Click here to view full article